These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 2786108)

  • 1. [The incidence of lung infection in patients with mucoviscidosis and the disease course with various pathogen spectra].
    Dietzsch HJ; Kossatz A; Lerche M
    Kinderarztl Prax; 1989 Feb; 57(2):81-7. PubMed ID: 2786108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.
    De Baets F; Schelstraete P; Van Daele S; Haerynck F; Vaneechoutte M
    J Cyst Fibros; 2007 Jan; 6(1):75-8. PubMed ID: 16793350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relations between the frequency of the DeltaF 508 mutation and the course of pulmonary disease in cystic fibrosis patients infected with Pseudomonas aeruginosa.
    Rosenecker J
    Eur J Med Res; 2000 Aug; 5(8):356-9. PubMed ID: 10958769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
    Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
    Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung transplantation for cystic fibrosis: 6-year follow-up.
    Quattrucci S; Rolla M; Cimino G; Bertasi S; Cingolani S; Scalercio F; Venuta F; Midulla F
    J Cyst Fibros; 2005 May; 4(2):107-14. PubMed ID: 15914093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early rise of anti-pseudomonas antibodies and a mucoid phenotype of pseudomonas aeruginosa are risk factors for development of chronic lung infection--a case control study.
    Pressler T; Frederiksen B; Skov M; Garred P; Koch C; Høiby N
    J Cyst Fibros; 2006 Jan; 5(1):9-15. PubMed ID: 16412706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy.
    Sims EJ; Clark A; McCormick J; Mehta G; Connett G; Mehta A;
    Pediatrics; 2007 Jan; 119(1):19-28. PubMed ID: 17200267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transtracheal aspiration in pulmonary infection in children with cystic fibrosis.
    Brook I; Fink R
    Eur J Respir Dis; 1983 Jan; 64(1):51-7. PubMed ID: 6825749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of IgG serum levels in cystic fibrosis].
    Vázquez Cordero C; Sánchez Obregón M; Molinuevo Alvaro J; Larrea Rementería F; Vitoria Cormenzana JC; Sojo Aguirre A
    An Esp Pediatr; 1988 Apr; 28(4):321-4. PubMed ID: 3400941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response to Pseudomonas aeruginosa in children with cystic fibrosis.
    Milagres LG; Castro TL; Garcia D; Cruz AC; Higa L; Folescu T; Marques EA
    Pediatr Pulmonol; 2009 Apr; 44(4):392-401. PubMed ID: 19283764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-operative infections in cystic fibrosis and non-cystic fibrosis patients after lung transplantation.
    Bonvillain RW; Valentine VG; Lombard G; LaPlace S; Dhillon G; Wang G
    J Heart Lung Transplant; 2007 Sep; 26(9):890-7. PubMed ID: 17845927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary infection in mild variant cystic fibrosis: implications for care.
    Lording A; McGaw J; Dalton A; Beal G; Everard M; Taylor CJ
    J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
    Tramper-Stranders GA; Wolfs TF; Fleer A; Kimpen JL; van der Ent CK
    Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth and lung function in Asian patients with cystic fibrosis.
    Callaghan BD; Hoo AF; Dinwiddie R; Balfour-Lynn IM; Carr SB
    Arch Dis Child; 2005 Oct; 90(10):1029-32. PubMed ID: 16177157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis.
    da Silva Filho LV; Tateno AF; Martins KM; Azzuz Chernishev AC; Garcia Dde O; Haug M; Meisner C; Rodrigues JC; Döring G
    Pediatr Pulmonol; 2007 Oct; 42(10):938-44. PubMed ID: 17722007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection and management of early Pseudomonas aeruginosa infection in patients with cystic fibrosis].
    Kernen Y; Sauty A; Roulet M
    Rev Med Suisse; 2005 Mar; 1(9):637-8, 640. PubMed ID: 15813341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of care and clinical condition in paediatric cystic fibrosis patients.
    Baumann U; Stocklossa C; Greiner W; von der Schulenburg JM; von der Hardt H
    J Cyst Fibros; 2003 Jun; 2(2):84-90. PubMed ID: 15463855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvements in lung function outcomes in children with cystic fibrosis are associated with better nutrition, fewer chronic pseudomonas aeruginosa infections, and dornase alfa use.
    McPhail GL; Acton JD; Fenchel MC; Amin RS; Seid M
    J Pediatr; 2008 Dec; 153(6):752-7. PubMed ID: 18760423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.